•  
  •  
  •  
  •  

2025-11-30 03:40:19

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Cantabil Retail India Ltd opens 3 new shops in November 2025
  • Advait Energy Transitions Ltd receives order from Malaysia
  • SRM Contractors Ltd receives ET Infra Leadership Award 2025
  • Ceinsys Tech Ltd receives additional order from MRSAC
  • Apeejay Surrendra Park Hotels Ltd inks MoU for 42 room hotel in Mathura

Keywords Selected:  SunPharmaAdvancedResearchCompany

Stock Report

  • SPARC announces consolidation of R&D laboratories and facilities
  • SPARC announces submission of IND Application for SBO-154 to USFDA
  • SPARC Announces Signing of Binding Letter of Intent with UCSF and Tiller Therapeutics for Pre-clinical Oncology Asset and Associated Intellectual Property
  • SPARC announces results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease
  • Sun Pharma Advanced Research Company Ltd Q3 FY24 loss at Rs. 99.65 crores
  • Sun Pharma Advanced Research Company Ltd Q2 FY24 loss at Rs. 86.42 crores
  • Sun Pharma Advanced Research Company Ltd Q4 FY2022-23 loss at Rs. 81.99 crores
  • Sun Pharma Advanced Research Company Ltd reports profit in Q3FY23
  • SEZABY™ approved by US FDA for the treatment of neonatal seizures
  • Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US
  • Sun Pharma Advanced Research Company Ltd Q2 FY2023 loss at Rs. 68.40 crores
  • Sun Pharma Advanced Research Company Ltd Q1FY23 loss widens to Rs. 82.35 crores
  • Sun Pharma Advanced Research Company Ltd Q4FY22 net loss widens to Rs. 71.05 crores
  • Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crores
  • SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting
  • SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma
  • SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target
  • Sun Pharma Advanced Research Company Ltd posts loss of Rs. 55.14 crore in Q2 FY22

Latest Post

  • Cantabil Retail India Ltd opens 3 new shops in November 2025
  • Advait Energy Transitions Ltd receives order from Malaysia
  • SRM Contractors Ltd receives ET Infra Leadership Award 2025
  • Ceinsys Tech Ltd receives additional order from MRSAC
  • Apeejay Surrendra Park Hotels Ltd inks MoU for 42 room hotel in Mathura


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024